Hyperthyroidism with interferon-ribavirin therapy for hepatitis C: A case report and proposed treatment algorithm [10]

American Journal of Gastroenterology

Volumn 95, Issue 10, 2000, Pages 2995-2996

  Harris, Danielle M ^a   Hespenheide, Elizabeth E ^a   Dalkin, Alan C ^a   Kirk, Susan E ^a   Ellis, Diane S ^b   Caldwell, Stephen H ^a,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE SODIUM; LIOTHYRONINE; PROPRANOLOL; REBETRON; TECHNETIUM; THYROTROPIN; THYROXINE;

ADULT; ALGORITHM; CASE REPORT; FEMALE; HEPATITIS C; HUMAN; HYPERTHYROIDISM; LETTER; PRIORITY JOURNAL; THYROIDITIS;

EID: 0033792764     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02016-5     Document Type: Letter

References (10)

1. Interferon-associated thyroid dysfunction in anti-D-related chronic hepatitis C
2. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha
3. Incidence and characteristics of thyroid dysfunction following interferon therapy in patients with chronic hepatitis C
4. Patients treated with interferon-alpha, interferon-beta, and interleukin-2 have a different thyroid autoantibody pattern than patients suffering from endogenous autoimmune thyroid disease
5. Prevalence and significance of thyroid autoantibodies in patients with chronic hepatitis C virus infection: A prospective controlled study
6. Prospective study on thyroid autoimmunity and dysfunction related to chronic hepatitis C and interferon therapy
7. Reversible primary hypothyroidism with blocking or stimulating type TSH binding inhibitor immunoglobulin following recombinant interferon-alpha therapy in patients with pre-existing thyroid disorders
8. Side effects of highdose interferon therapy for chronic hepatitis C
9. Interferon-alpha-induced thyroid dysfunction in patients with chronic active hepatitis C: A transient, reversible and self-limited dysfunction
10. Nuclear medicine and endocrinology: Diagnosis and management